Breaking News

Diatherix Eurofins Launches SARS-CoV-2 Virus Identification Test

New COVID-19 Panel tests for the SARS-CoV-2 virus along with five bacterial pathogens

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

A provider of respiratory viral and bacterial testing, Diatherix Eurofins has developed a test for the SARS-CoV-2 virus, the cause of the COVID-19 respiratory infection, as part of its proprietary respiratory testing portfolio. Diatherix will begin accepting specimens for testing as of March 17, 2020.   Diatherix has developed the new COVID-19 Panel which includes the SARS-CoV-2 virus along with five bacterial pathogens which are known to be more prevalent and relevant to the severity of complic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters